Skip to main content

Advertisement

Log in

Protein kinase C regulation of GABAA receptors

  • Review
  • Published:
Cellular and Molecular Life Sciences CMLS Aims and scope Submit manuscript

Abstract.

Pharmacological studies with drugs that activate or inhibit several protein kinase C (PKC) isozymes have identified the PKC family of serine-threonine kinases as important in the regulation of γ-aminobutyric acid type A (GABAA) receptor function. PKC modulates GABAA receptor surface density, chloride conductance and receptor sensitivity to positive allosteric modulators such as neurosteroids, ethanol, benzodiazepines and barbiturates. Recent studies using PKC isozyme-selective reagents and gene-targeted mice have begun to identify critical roles for three isozymes, PKCβII, PKCɛ and PKCγ, in various aspects of GABAA receptor regulation. Progress in this field touches upon therapeutic areas that are of great clinical importance such as anxiety and addiction. Increased understanding of how PKC regulates GABAA receptors and which PKC isozymes are involved holds promise for development of new treatments for diverse neuropsychiatric disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R. O. Messing.

Additional information

Received 2 August 2004; received after revision 17 August 2004; accepted 21 August 2004

Rights and permissions

Reprints and permissions

About this article

Cite this article

Song, M., Messing, R.O. Protein kinase C regulation of GABAA receptors. CMLS, Cell. Mol. Life Sci. 62, 119–127 (2005). https://doi.org/10.1007/s00018-004-4339-x

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00018-004-4339-x

Key words.

Navigation